Epileptic encephalopathy, movement disorder, and the yin and yang of

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. The Schwann cell-specific G-protein Gαo (Gnao1) is a cell-intrinsic controller contributing to the regulation of myelination in peripheral nerve system.Acta neuropathologica communications · 2024
   Article
2. GNAO1-related neurodevelopmental disorder: Literature review and caregiver survey.Epilepsy & behavior reports · 2023
   Article
3. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region.Epilepsia · 2019
   Article
4. [Recurrent convulsion and pulmonary infection complicated by psychomotor retardation in an infant].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2018
   Article

Corrections and comments

• Comment on
  Movement disorder in2017

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as